-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Krystal Biotech, Raises Price Target to $403

Benzinga·06/18/2026 14:33:46
Listen to the news
TD Cowen analyst Ritu Baral maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $306 to $403.